Literature DB >> 15453552

Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial.

Helen Gotsopoulos1, John J Kelly, Peter A Cistulli.   

Abstract

STUDY
OBJECTIVE: To investigate the short-term effect (4 weeks) of oral appliance therapy for obstructive sleep apnea on blood pressure.
DESIGN: Randomized, controlled, crossover trial.
SETTING: Multidisciplinary sleep disorders clinic in a university teaching hospital. PATIENTS: Sixty-one patients diagnosed with obstructive sleep apnea on polysomnography (apnea hypopnea index > or = 10 per hour and at least 2 of the following symptoms--daytime sleepiness, snoring, witnessed apneas, fragmented sleep; age > 20 years; and minimum mandibular protrusion of 3 mm). INTERVENTION: A mandibular advancement splint (MAS) and control oral appliance for 4 weeks each. MEASUREMENTS AND
RESULTS: Polysomnography and 24-hour ambulatory blood pressure monitoring were carried out at baseline and following each 4-week intervention period. Patients showed a 50% reduction in mean apnea hypopnea index with MAS compared with the control and a significant improvement in both minimum oxygen saturation and arousal index. There was a significant reduction with the MAS in mean (+/- SEM) 24-hour diastolic blood pressure (1.8 +/- 0.5 mmHg) compared with the control (P = .001) but not in 24-hour systolic blood pressure. Awake blood-pressure variables were reduced with the MAS by an estimated mean (+/- SEM) of 3.3 +/- 1.1 mmHg for systolic blood pressure (P = .003) and 3.4 +/- 0.9 mmHg for diastolic blood pressure (P < .0001). There was no significant difference in blood pressure measured asleep.
CONCLUSION: Oral appliance therapy for obstructive sleep apnea over 4 weeks results in a reduction in blood pressure, similar to that reported with continuous positive airway pressure therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15453552     DOI: 10.1093/sleep/27.5.934

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  71 in total

Review 1.  Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management.

Authors:  Stephen K Williams; Joseph Ravenell; Girardin Jean-Louis; Ferdinand Zizi; James A Underberg; Samy I McFarlane; Gbenga Ogedegbe
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 2.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

3.  Evaluation of the impact of a clinical pathway on the organization of a multidisciplinary dental sleep clinic.

Authors:  D M Ten Berge; M J Braem; A Altenburg; M Dieltjens; P H Van de Heyning; K Vanhaecht; O M Vanderveken
Journal:  Sleep Breath       Date:  2013-09-03       Impact factor: 2.816

4.  The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea.

Authors:  Ryo Otsuka; Fernanda Ribeiro de Almeida; Alan A Lowe; Wolfgang Linden; Frank Ryan
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

Review 5.  Oral appliances for obstructive sleep apnoea.

Authors:  J Lim; T J Lasserson; J Fleetham; J Wright
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

6.  Long-term effectiveness of oral appliance versus CPAP therapy and the emerging importance of understanding patient preferences.

Authors:  Fernanda R Almeida; Nick Bansback
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

7.  Mandibular advancement splint as short-term alternative treatment in patients with obstructive sleep apnea already effectively treated with continuous positive airway pressure.

Authors:  Fernanda R Almeida; Alan Mulgrew; Najib Ayas; Hiroko Tsuda; Alan A Lowe; Nurit Fox; Sandra Harrison; John A Fleetham
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Mandibular advancement device and CPAP upon cardiovascular parameters in OSA.

Authors:  Cibele Dal-Fabbro; Silvério Garbuio; Vânia D'Almeida; Fátima D Cintra; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2014-01-26       Impact factor: 2.816

10.  Mandibular advancement splint titration in obstructive sleep apnoea.

Authors:  A J Campbell; G Reynolds; H Trengrove; A M Neill
Journal:  Sleep Breath       Date:  2008-11-07       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.